Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03800238 · ClinicalTrials.gov registry record · NA
Telehealth Powerful Tools for Caregivers Effectiveness Study
A NA study of Caregivers, sponsored by Concordia University Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
- 13
- Study locations
NCT03800238: Completed NA study of Caregivers, sponsored by Concordia University Wisconsin.
NCT03800238 is a NA study of Caregivers that has completed, run by Concordia University Wisconsin. The registered enrollment target is 115 participants, above the 93-participant average among 15 other Caregivers trials with a reported enrollment target (24% higher). The trial reports 13 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03800238, a NA study of Caregivers, has completed, sponsored by Concordia University Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of this research is to examine the efficacy of telehealth as a delivery format for an education-based caregiver wellness program focusing on self-care. The study will examine two research questions. 1) Are outcomes equivalent for caregivers in an education based-wellness program delivered via telehealth and one delivered in person as measured by a general rating of health, the Center for Epidemiologic Studies Depression Scale - Revised (CESD-R), self-care behaviors (health self-care neglect, frequency of stress management and relaxation activities, and exercise frequency), self-efficacy, use of community resources, and the Bakas Caregiving Outcomes Scale (BCOS)? 2) Is class attendance equivalent for classes delivered via telehealth and in person? This research involves a specific education-based caregiver wellness program called Powerful Tools for Caregivers (PTC). PTC is an evidence-based six-week program that addresses caregiver health by promoting self-care. Collaborating community organizations offer the program at little to no cost. This study will employ a quasi-experimental nonequivalent pretest-posttest design to compare outcomes from in-person to telehealth delivered PTC classes. PTC classes are conducted by a pair of class leaders who model concepts. Each pair of class leaders will conduct both a telehealth and in-person PTC class. Collaborating community organizations will recruit 105 caregivers to attend PTC classes delivered by 7 pairs of class leaders. Telehealth classes will use VSee software to allow caregivers to participate in the PTC program synchronously via secure videoconferencing from their own home. VSee is a free software program designed to deliver secure telehealth services. Class leaders will guide participants in installation of the software on their home computer. Participants will undergo assessment one week before and one week after the PTC program, and at six-month follow up. Outcome measures replicate previous PTC res
Primary Outcome
Questionnaire assessing symptoms of depression; each question is rated on a 5-point Likert scale; total scores range from zero to 80 with a higher score indicating greater symptoms of depression.
Conditions Studied
Interventions
- BEHAVIORAL Telehealth Delivery Format
- BEHAVIORAL Standard Delivery Format
Study Locations (13)
California
- OPICA Adult Day Program - Los Angeles
- Health Projects Center - Santa Cruz
Florida
- Tampa General Hospital - Tampa
Idaho
- Southeast Idaho Council of Governments Inc - Pocatello
Iowa
- Iowa State University (ISU) Extension and Outreach - Webster City
Michigan
- Michigan State University - Grand Rapids
Minnesota
- Lutheran Social Service - Moorhead
Nebraska
- Executive Services Corps - NE - Plattsmouth
New Hampshire
- Concord Regional Visiting Nurse Association (VNA) - Concord
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2020-10-08 |
| Phase | NA |
What the finished NCT03800238 record still lists
NCT03800238 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, above the 93-participant average among 15 other Caregivers trials with a reported enrollment target (24% higher).
The record links to 1 condition, with Caregivers appearing as the primary indexed condition, and to 2 interventions - of which Telehealth Delivery Format is the first listed.
NCT03800238 lists 13 locations in 12 states (California, Florida, Idaho).
Frequently Asked Questions
What is clinical trial NCT03800238 about?
NCT03800238 is a clinical study titled "Telehealth Powerful Tools for Caregivers Effectiveness Study". The purpose of this research is to examine the efficacy of telehealth as a delivery format for an education-based caregiver wellness program focusing on self-care. The study will examine two research questions. 1) Are outcomes equivalent for caregivers in an education based-wellness program delivere...
What is the current status of trial NCT03800238?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2019-02-01. Estimated completion is 2020-10-08.
What conditions does trial NCT03800238 study?
This clinical trial studies the following conditions: Caregivers.
What interventions are being tested in trial NCT03800238?
The interventions under investigation include: Telehealth Delivery Format (BEHAVIORAL), Standard Delivery Format (BEHAVIORAL).
Who is sponsoring clinical trial NCT03800238?
This trial is sponsored by Concordia University Wisconsin, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03800238 being conducted?
This trial has 13 study locations across California, Florida, Idaho, Iowa, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Caregivers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03800238's enrollment target sits among peer trials
115 4th of 15 higher than 12 of 15 other Caregivers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Caregivers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
Pilot Study of Hospital GamePlan4Care
RECRUITING · NA
-
Cereset Research for Caregivers
RECRUITING · NA
-
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
RECRUITING · NA
-
Mind-body Resilience Program for Cardiac Arrest Survivors and Their Caregivers: Recovering Together After Cardiac Arrest
RECRUITING · NA
-
Supporting Care Partners' Well-Being With Artificial Intelligence (AI) Chatbots
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI